Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) EBITDA Margin: 2019-2024

Historic EBITDA Margin for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to 4.62%.

  • Agilon Health's EBITDA Margin rose 1100.0% to 8.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.16%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 4.62% for FY2024, which is 5700.0% up from last year.
  • Latest data reveals that Agilon Health reported EBITDA Margin of 4.62% as of FY2024, which was up 5700.0% from 5.19% recorded in FY2023.
  • Over the past 5 years, Agilon Health's EBITDA Margin peaked at 4.25% during FY2022, and registered a low of 24.31% during FY2021.
  • For the 5-year period, Agilon Health's EBITDA Margin averaged around 8.57%, with its median value being 4.62% (2024).
  • In the last 5 years, Agilon Health's EBITDA Margin tumbled by -198400bps in 2021 and then surged by 200700bps in 2022.
  • Annual analysis of 5 years shows Agilon Health's EBITDA Margin stood at 4.47% in 2020, then tumbled by -444bps to 24.31% in 2021, then soared by 83bps to 4.25% in 2022, then decreased by -22bps to 5.19% in 2023, then increased by 11bps to 4.62% in 2024.
  • Its last three reported values are 4.62% in FY2024, 5.19% for FY2023, and 4.25% during FY2022.